Clinical Study

Efficacy of Tumor-Infiltrating Lymphocytes Combined with IFN-α in Chinese Resected Stage III Malignant Melanoma

Table 6

Distribution of adverse events.

Side effectsArm 1Arm 2
Grade 1/2Grade 3/4Grade 1/2Grade 3/4

Fever130200
Arthralgia50130
Nausea30120
Leukopenia4080
Liver dysfunction2090
Anemia30100
Vitiligo2010